|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,956.00 GBX | +2.06% |
|
-1.19% | +7.21% |
| 16/07 | India's Serum Institute partners with Gates MRI to make experimental TB vaccine | RE |
| 15/07 | GSK Completes $10.6 Billion Acquisition of Nuvalent | MT |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 19 | ||||||||
| 27 | ||||||||
| 22 | ||||||||
| 28 | ||||||||
| 18 | ||||||||
| 21 | ||||||||
| 22 | ||||||||
| 24 | ||||||||
| 29 | ||||||||
| 27 | ||||||||
| 26 | ||||||||
| 25 | ||||||||
| 24 | ||||||||
| 23 | ||||||||
| 15 | ||||||||
| 18 | ||||||||
| 15 | ||||||||
| 15 | ||||||||
| 17 | ||||||||
| Average | 22 | |||||||
| Weighted average by Cap. | 24 |
- Stock Market
- Stocks
- GSK Stock
- Sector GSK plc
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















